PHARMACY

With the launch of Vigadrone, its generic of Sabril — a first-line treatment for infantile spasms in infants with tuberous sclerosis complex — Upsher-Smith is offering an enhanced level of service around the drug.

The National Community Pharmacists Association applauded the Senate for passage of S. 2554, the Patient Right to Know Drug Prices Act, saying the legislation will prohibit "gag clauses" in private health plans.

Genoa Healthcare, which operates more than 425 pharmacies in behavioral health centers, is opening its first pharmacy in California.

Richard Schmitz, a former healthcare public affairs executive at PR firm Golin, is joining PQA as senior director of communication.

NACDS praised The Patient Right to Know Drug Prices Act (S. 2554), which is part of the effort to empower pharmacists to help patients lower out-of-pocket drug costs.

Drug Store News sat down with Christie Welton, clinical executive at Elsevier, who discussed the company's role in helping simplify the time-consuming obstacle of drug database updates.

The Food and Drug Administration has approved an opioid analgesic risk and evaluation and mitigation strategy as part of a broader set of measures to address the opioid crisis.

The Food and Drug Administration approved Teva Pharmaceutical's Ajovy, which is indicated for the preventive treatment of migraine in adults.